Drug name,UC1 (Drug name),Drug Name Details (Optional),UC2 (Drug Name Details),Active ingredients,UC3 (Active Ingredients),Brand,UC4 (Brand),Route,UC5 (Route),Form,UC6 (Form),Strength,UC7 (Strength),Units,UC8 (Units),Immediate Packaging,UC9 (Immediate Packaging),ignore this column -- feedback for team
COVID-19 vaccine (mRNA-CV),11c672231,"Southern Hemisphere 2021, Egg-based",44ec84bg,tozinameran (BNT162b2),6ka0a68rq,Pfizer/BioNTech,fcaqd62ec,Intramuscular,b52316e87,Injection (suspension),235ca8bc5,225 microgram (30 microgram),zg10c351j,2.25 ml (0.3ml),95b89q2y5,Ready To Use,5ec96b214,
COVID-19 vaccine (mRNA-CV),11c672231,,,tozinameran (BNT162b2),5g90ah84d,Pfizer/BioNTech,fcaqd62ec,Intramuscular,b52316e87,Injection (suspension),235ca8bc5,65 microgram (10 microgram),yf09b240h,1.3 ml (0.2ml),94a88r1z4,Dilute To Use,5ec96b214,
COVID-19 vaccine (mRNA-CV),11c672231,,,tozinameran (BNT162b2),d4a6cb716,Pfizer/BioNTech,fcaqd62ec,Intramuscular,b52316e87,Injection (suspension),235ca8bc5,0.1 mg per ml,3fd9b24ac,0.45 ml,54c8d91b4,Vial,5ec96b214,